James Childs, Chair of the Firm’s Maynard Venture Partners practice, participated in two panel presentations during this week’s BioAlabama Virtual Annual Conference. The first panel presentation discussed the roll-out of Alabama’s Strategic Bioscience Economic Development Roadmap. James moderated the second panel which featured a Bioscience Angel Investor Forum with private investors Tommy Satterfield and Daniel Coleman. BioAlabama is the leading advocate for Alabama’s bioeconomy, representing Alabama on a national and international stage, promoting the intellectual and innovative capital that make Alabama a premier place to invest, start, and grow in bioscience. James serves on the Board of Directors and Executive Committee of BioAlabama, and he is Co-Chair of its Start-Up & Technology Transfer Committee.
This year’s virtual Annual Conference brings State and Global leaders together to discuss the BioTech community and its rapid response to the COVID pandemic, as well as how the researchers, scientists, and business leaders are bringing the same sense of urgency to solving the world’s most challenging health and environmental problems. Keynote speakers at the Annual Conference include Dr. Regina Benjamin, 18th U.S. Surgeon General; Bob Hess, Vice Chair of Newmark Knight Frank; U.S. Senator Doug Jones; and Dr. Michelle McMurry-Heath, President and CEO of BIO.